Literature DB >> 19236843

Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase.

Suthat Liangpunsakul1, Sung-Eun Wou, Kevin D Wineinger, Yan Zeng, Izabela Cyganek, Hiremagalur N Jayaram, David W Crabb.   

Abstract

BACKGROUND: AMP-dependent protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR) alpha facilitate fatty acid oxidation. We have shown that treatment of hepatoma cells with ethanol or feeding ethanol-containing diets to mice inhibited both PPARalpha and AMPK activity. Importantly, WY-14,643 reversed the development of fatty liver in alcohol-fed mice. Whether WY-14,643, a PPARalpha agonist, has any effects on AMPK is not known. The aim of this study was to investigate the effect of WY-14,643 on AMPK activity.
METHODS: The effect of WY-14,643 on AMPK phosphorylation and activity were examined in rat hepatoma cells (H4IIEC3). The effect of WY-14,643 on upstream kinases of AMPK, PKC-zeta/LKB1, intracellular AMP:ATP ratio, oxidative stress, and AMPK gene expression were studied.
RESULTS: Treatment of the H4IIEC3 cells with WY-14,643 for 24h led to 60% increase in the phosphorylation of AMPK. The effect of WY-14,643 on AMPK phosphorylation is PKC-zeta/LKB1 independent. WY-14,643 did not alter the levels of intracellular AMP:ATP ratio and it did not increase the levels of reactive oxygen species at 24-h of treatment. WY-14,643-induced AMPK alpha subunit expression by 2- to 2.5-fold, but there was no change in AMPKalpha subunit protein at 24h. The effect of WY-14,643 on AMPK phosphorylation did not altered by the presence of an NADPH oxidase inhibitor.
CONCLUSIONS: WY-14,643 induced AMPKalpha subunit phosphorylation and the activity of the enzyme. This was associated with induction of AMPKalpha1 and alpha2 mRNA, but the mechanism for this activation is uncertain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236843      PMCID: PMC2692688          DOI: 10.1016/j.abb.2009.02.006

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  22 in total

1.  Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.

Authors:  I Rusyn; S Yamashina; B H Segal; R Schoonhoven; S M Holland; R C Cattley; J A Swenberg; R G Thurman
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

2.  Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase.

Authors:  Simon A Hawley; David A Pan; Kirsty J Mustard; Louise Ross; Jenny Bain; Arthur M Edelman; Bruno G Frenguelli; D Grahame Hardie
Journal:  Cell Metab       Date:  2005-07       Impact factor: 27.287

3.  The regulation of AMP-activated protein kinase by H(2)O(2).

Authors:  S L Choi; S J Kim; K T Lee; J Kim; J Mu; M J Birnbaum; S Soo Kim; J Ha
Journal:  Biochem Biophys Res Commun       Date:  2001-09-14       Impact factor: 3.575

4.  Peroxisome proliferator-activated receptor alpha induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-alpha activation properties.

Authors:  Elisabeth Teissier; Atsushi Nohara; Giulia Chinetti; Réjane Paumelle; Bertrand Cariou; Jean-Charles Fruchart; Ralf P Brandes; Ajay Shah; Bart Staels
Journal:  Circ Res       Date:  2004-11-11       Impact factor: 17.367

5.  The role of AMP-activated protein kinase in the action of ethanol in the liver.

Authors:  Min You; Michinaga Matsumoto; Christine M Pacold; Won Kyoo Cho; David W Crabb
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

6.  Determination of NAD pyrophosphorylase activity in biological samples.

Authors:  E Paulik; H N Jayaram; G Weber
Journal:  Anal Biochem       Date:  1991-08-15       Impact factor: 3.365

7.  Effect of ethanol on hydrogen peroxide-induced AMPK phosphorylation.

Authors:  Suthat Liangpunsakul; Sung-Eun Wou; Yan Zeng; Ruth A Ross; Hiremagalur N Jayaram; David W Crabb
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-02       Impact factor: 4.052

8.  Activation of 5'-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite.

Authors:  Ming-Hui Zou; Xiu-Yun Hou; Chao-Mei Shi; Stacy Kirkpatick; Feng Liu; Mitchell H Goldman; Richard A Cohen
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

9.  Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice.

Authors:  Monika Fischer; Min You; Michinaga Matsumoto; David W Crabb
Journal:  J Biol Chem       Date:  2003-06-05       Impact factor: 5.157

10.  Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels.

Authors:  Andrew J Murray; Marcello Panagia; David Hauton; Geoffrey F Gibbons; Kieran Clarke
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

View more
  10 in total

1.  The Med1 subunit of the mediator complex induces liver cell proliferation and is phosphorylated by AMP kinase.

Authors:  Navin Viswakarma; Yuzhi Jia; Liang Bai; Qian Gao; Bingliang Lin; Xiaohong Zhang; Parimal Misra; Ajay Rana; Sanjay Jain; Frank J Gonzalez; Yi-Jun Zhu; Bayar Thimmapaya; Janardan K Reddy
Journal:  J Biol Chem       Date:  2013-08-13       Impact factor: 5.157

2.  Phytanic acid activates PPARα to promote beige adipogenic differentiation of preadipocytes.

Authors:  Hanning Wang; Xueying Mao; Min Du
Journal:  J Nutr Biochem       Date:  2019-03-11       Impact factor: 6.048

3.  Ethanol sensitizes mitochondria to the permeability transition by inhibiting deacetylation of cyclophilin-D mediated by sirtuin-3.

Authors:  Nataly Shulga; John G Pastorino
Journal:  J Cell Sci       Date:  2010-11-09       Impact factor: 5.285

4.  AMPK-Dependent Metabolic Regulation by PPAR Agonists.

Authors:  Woo Hyung Lee; Sang Geon Kim
Journal:  PPAR Res       Date:  2010-08-08       Impact factor: 4.964

5.  Comparative Evaluation of Gemcabene and Peroxisome Proliferator-Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease.

Authors:  Charles L Bisgaier; Daniela C Oniciu; Rai Ajit K Srivastava
Journal:  J Cardiovasc Pharmacol       Date:  2018-07       Impact factor: 3.105

6.  Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome.

Authors:  James J DiNicolantonio; Mark McCarty; James OKeefe
Journal:  Open Heart       Date:  2019-08-05

Review 7.  Peroxisome Proliferator-Activated Receptors and Caloric Restriction-Common Pathways Affecting Metabolism, Health, and Longevity.

Authors:  Kalina Duszka; András Gregor; Hervé Guillou; Jürgen König; Walter Wahli
Journal:  Cells       Date:  2020-07-16       Impact factor: 6.600

8.  Xylazine Activates Adenosine Monophosphate-Activated Protein Kinase Pathway in the Central Nervous System of Rats.

Authors:  Xing-Xing Shi; Bai-Shuang Yin; Peng Yang; Hao Chen; Xin Li; Li-Xue Su; Hong-Gang Fan; Hong-Bin Wang
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

9.  Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARα.

Authors:  Dariusz Ratman; Viacheslav Mylka; Nadia Bougarne; Michal Pawlak; Sandrine Caron; Nathalie Hennuyer; Réjane Paumelle; Lode De Cauwer; Jonathan Thommis; Mark H Rider; Claude Libert; Sam Lievens; Jan Tavernier; Bart Staels; Karolien De Bosscher
Journal:  Nucleic Acids Res       Date:  2016-08-30       Impact factor: 16.971

Review 10.  Peroxisome Proliferator-Activated Receptors as Molecular Links between Caloric Restriction and Circadian Rhythm.

Authors:  Kalina Duszka; Walter Wahli
Journal:  Nutrients       Date:  2020-11-12       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.